Talnetant
- Generic Name
- Talnetant
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C25H22N2O2
- CAS Number
- 174636-32-9
- Unique Ingredient Identifier
- CZ3T9T146K
- Background
Talnetant (SB-223,412) is a neurokinin 3 receptor antagonist developed by GlaxoSmithKline, which is being researched for several different functions, primarily for irritable bowel syndrome and as a potential antipsychotic drug for the treatment of schizophrenia.
- Indication
Investigated for use/treatment in schizophrenia and schizoaffective disorders, irritable bowel syndrome (IBS), and chronic obstructive pulmonary disease (COPD).
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath